The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 19, 2023

Filed:

Jun. 08, 2018
Applicant:

David S. Goldsmith, Atlanta, GA (US);

Inventor:

David S. Goldsmith, Atlanta, GA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 10/02 (2006.01); A61M 5/14 (2006.01); A61N 5/10 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61M 39/24 (2006.01); A61M 1/36 (2006.01); A61F 2/04 (2013.01); A61M 5/168 (2006.01); A61M 60/126 (2021.01); A61B 17/02 (2006.01); A61B 17/00 (2006.01); A61B 17/3205 (2006.01); A61M 3/02 (2006.01); A61M 27/00 (2006.01); A61B 1/32 (2006.01);
U.S. Cl.
CPC ...
A61B 10/02 (2013.01); A61B 1/32 (2013.01); A61F 2/04 (2013.01); A61M 1/3618 (2014.02); A61M 1/3666 (2013.01); A61M 3/0279 (2013.01); A61M 5/14 (2013.01); A61M 5/14228 (2013.01); A61M 5/14276 (2013.01); A61M 5/16813 (2013.01); A61M 5/1723 (2013.01); A61M 27/008 (2013.01); A61M 39/24 (2013.01); A61M 60/126 (2021.01); A61N 5/1002 (2013.01); A61B 17/3205 (2013.01); A61B 2017/00566 (2013.01); A61B 2017/00876 (2013.01); A61B 2017/0212 (2013.01); A61F 2002/044 (2013.01); A61F 2220/0083 (2013.01); A61M 5/14244 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/0288 (2013.01); A61M 2210/1025 (2013.01); A61M 2210/1078 (2013.01); A61M 2210/1085 (2013.01); A61M 2240/00 (2013.01); A61N 2005/1094 (2013.01);
Abstract

Described are means for the direct and continuous connection of a catheter to the lumen of any tubular anatomical structure, or ductus, without medically significant leakage. A port implanted at the body surface with piping to a periductal collar allows drug or radionuclide delivery that bypasses the upstream lumen. The port allows injection, infusion, aspiration, or attachment of an automatic ambulatory pump. A superparamagnetic nanoparticle carrier-bound drug, for example, can be introduced into the lumen to pass downstream until the particles, with or without the drug still bound, are drawn into the lumen wall by a magnetized jacket surrounding the ductus. Such constitutes a method of drug targeting whereby a segment of a vessel or the territory supplied by a branch of that segment can be circumscribed for exposure to the drug. A jacket with side-entry connector positioned in surrounding relation to a lesion requiring treatment can itself be magnetized.


Find Patent Forward Citations

Loading…